BR112017010588A2 - formas cristalinas de inibidores de parp - Google Patents
formas cristalinas de inibidores de parpInfo
- Publication number
- BR112017010588A2 BR112017010588A2 BR112017010588-8A BR112017010588A BR112017010588A2 BR 112017010588 A2 BR112017010588 A2 BR 112017010588A2 BR 112017010588 A BR112017010588 A BR 112017010588A BR 112017010588 A2 BR112017010588 A2 BR 112017010588A2
- Authority
- BR
- Brazil
- Prior art keywords
- crystalline forms
- parp inhibitors
- parp
- inhibitors
- crystalline
- Prior art date
Links
- 239000012661 PARP inhibitor Substances 0.000 title 1
- 229940121906 Poly ADP ribose polymerase inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462084652P | 2014-11-26 | 2014-11-26 | |
| US62/084,652 | 2014-11-26 | ||
| PCT/US2015/062572 WO2016086080A1 (en) | 2014-11-26 | 2015-11-25 | Crystalline forms of parp inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017010588A2 true BR112017010588A2 (pt) | 2018-05-15 |
Family
ID=54849709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017010588-8A BR112017010588A2 (pt) | 2014-11-26 | 2015-11-25 | formas cristalinas de inibidores de parp |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10150772B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3224259A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017535564A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170088894A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107207511A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015353549A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017010588A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2967828A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1244006A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL252162A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2017006679A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2017120655A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016086080A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
| WO2008063644A1 (en) * | 2006-11-20 | 2008-05-29 | Cephalon, Inc. | Method of radio-sensitizing tumors using a radio-sensitizing agent |
| JP2013503173A (ja) * | 2009-08-26 | 2013-01-31 | セファロン、インク． | 多環系化合物の新規形態 |
-
2015
- 2015-11-25 CA CA2967828A patent/CA2967828A1/en not_active Abandoned
- 2015-11-25 AU AU2015353549A patent/AU2015353549A1/en not_active Abandoned
- 2015-11-25 WO PCT/US2015/062572 patent/WO2016086080A1/en not_active Ceased
- 2015-11-25 KR KR1020177016523A patent/KR20170088894A/ko not_active Withdrawn
- 2015-11-25 US US15/529,883 patent/US10150772B2/en not_active Expired - Fee Related
- 2015-11-25 CN CN201580063386.3A patent/CN107207511A/zh active Pending
- 2015-11-25 RU RU2017120655A patent/RU2017120655A/ru not_active Application Discontinuation
- 2015-11-25 MX MX2017006679A patent/MX2017006679A/es unknown
- 2015-11-25 JP JP2017527299A patent/JP2017535564A/ja active Pending
- 2015-11-25 BR BR112017010588-8A patent/BR112017010588A2/pt not_active Application Discontinuation
- 2015-11-25 EP EP15808507.6A patent/EP3224259A1/en not_active Withdrawn
- 2015-11-25 HK HK18103530.1A patent/HK1244006A1/zh unknown
-
2017
- 2017-05-08 IL IL252162A patent/IL252162A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017535564A (ja) | 2017-11-30 |
| CN107207511A (zh) | 2017-09-26 |
| US10150772B2 (en) | 2018-12-11 |
| MX2017006679A (es) | 2018-07-06 |
| WO2016086080A1 (en) | 2016-06-02 |
| EP3224259A1 (en) | 2017-10-04 |
| CA2967828A1 (en) | 2016-06-02 |
| IL252162A0 (en) | 2017-07-31 |
| RU2017120655A3 (cg-RX-API-DMAC7.html) | 2018-12-14 |
| KR20170088894A (ko) | 2017-08-02 |
| US20170267683A1 (en) | 2017-09-21 |
| AU2015353549A1 (en) | 2017-06-01 |
| RU2017120655A (ru) | 2018-12-14 |
| HK1244006A1 (zh) | 2018-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263586B (en) | Inhibitors of the menin-mll interaction | |
| IL257880B (en) | Beta-lactamase inhibitors | |
| EP3541932A4 (en) | INHIBITORS OF CRISPR-CAS9 | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| EP3377059A4 (en) | INHIBITORS OF CXCR2 | |
| DK3371171T3 (da) | Inhibitorer af RET | |
| LT3303334T (lt) | Tirozinkinazės inhibitoriai | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| HUE042335T2 (hu) | ROR-gamma dihidropirrolopiridin inhibitorai | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| EP3386590A4 (en) | BICYCLIC INHIBITORS OF PAD4 | |
| EP3247692A4 (en) | INHIBITORS OF TRKA KINASE | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| EP3313828A4 (en) | METALLO-BETA-Lactamase INHIBITORS | |
| CL2016002638A1 (es) | Nuevos inhibidores de la nitrificación | |
| EP3386505A4 (en) | AZA-BENZIMIDAZOLINHIBITORS OF PAD4 | |
| DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
| DK3132009T3 (da) | Fremgangsmåde | |
| DK3204352T3 (da) | Hæmmere af lysin-gingipain | |
| DK3114120T3 (da) | Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere | |
| DK3283210T3 (da) | Fremgangsmåde | |
| HUE054721T2 (hu) | Mikrokapszulázott nitrifikáció-gátló készítmények | |
| MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
| EP3227309C0 (en) | CRYSTALLINE DIFUCOSYLLACTOSE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |